
Results
50
Mid-Large Cap Stocks
50 companies
Abbott India
Market Cap: ₹610.6b
Operates as a pharmaceutical company in India.
500488
₹28,735.45
7D
3.1%
1Y
-17.0%
Procter & Gamble Health
Market Cap: ₹111.3b
Manufactures and markets pharmaceuticals and chemical products in India and internationally.
500126
₹6,703.25
7D
-2.1%
1Y
15.0%
Alembic Pharmaceuticals
Market Cap: ₹156.9b
An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.
APLLTD
₹798.35
7D
-4.9%
1Y
-21.6%
Dr. Reddy's Laboratories
Market Cap: ₹971.7b
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,166.50
7D
-4.7%
1Y
-7.8%
Caplin Point Laboratories
Market Cap: ₹189.1b
Engages in the development, production, marketing, and export of generic formulations and branded products in India.
524742
₹2,487.15
7D
-6.9%
1Y
18.4%
Pfizer
Market Cap: ₹212.8b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,652.40
7D
-1.0%
1Y
-12.0%
Alkem Laboratories
Market Cap: ₹669.7b
A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
ALKEM
₹5,602.00
7D
-1.9%
1Y
12.1%
Sun Pharmaceutical Industries
Market Cap: ₹4.7t
A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.
SUNPHARMA
₹1,954.00
7D
0.2%
1Y
15.5%
Cipla
Market Cap: ₹1.1t
Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
CIPLA
₹1,393.00
7D
-2.6%
1Y
-6.4%
Jubilant Pharmova
Market Cap: ₹153.8b
Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.
530019
₹970.85
7D
-4.8%
1Y
-17.4%
Granules India
Market Cap: ₹211.1b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.
532482
₹851.85
7D
-5.7%
1Y
78.9%
Divi's Laboratories
Market Cap: ₹1.9t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹7,305.00
7D
-0.2%
1Y
10.4%
J. B. Chemicals & Pharmaceuticals
Market Cap: ₹387.3b
Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
506943
₹2,412.25
7D
0%
1Y
42.3%
Lupin
Market Cap: ₹1.1t
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹2,396.00
7D
-4.2%
1Y
23.3%
Glenmark Pharmaceuticals
Market Cap: ₹622.3b
Develops, manufactures, and sells generics, specialty medicines, and over the counter (OTC) pharmaceutical products in India, North America, Europe, and internationally.
GLENMARK
₹2,205.10
7D
-3.6%
1Y
2.8%
Torrent Pharmaceuticals
Market Cap: ₹1.9t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.
500420
₹5,065.80
7D
1.3%
1Y
44.1%
NATCO Pharma
Market Cap: ₹164.5b
A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹918.55
7D
-4.9%
1Y
-8.1%
Syngene International
Market Cap: ₹160.5b
A contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally.
SYNGENE
₹403.25
7D
-3.9%
1Y
-39.8%
Marksans Pharma
Market Cap: ₹111.5b
Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.
MARKSANS
₹246.10
7D
-10.6%
1Y
6.3%
Indegene
Market Cap: ₹117.7b
Operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
INDGN
₹488.50
7D
-4.4%
1Y
-12.2%
Concord Biotech
Market Cap: ₹132.7b
A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.
CONCORDBIO
₹1,268.50
7D
-5.8%
1Y
-34.2%
Aurobindo Pharma
Market Cap: ₹876.5b
A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.
AUROPHARMA
₹1,523.40
7D
-1.6%
1Y
36.7%
Eris Lifesciences
Market Cap: ₹193.4b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
ERIS
₹1,395.60
7D
-6.2%
1Y
-21.8%
Ajanta Pharma
Market Cap: ₹429.6b
A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.
AJANTPHARM
₹3,439.90
7D
-0.4%
1Y
23.0%
Ipca Laboratories
Market Cap: ₹449.4b
An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.
IPCALAB
₹1,771.20
7D
-6.3%
1Y
15.0%
Sanofi Consumer Healthcare India
Market Cap: ₹107.1b
Operates as a fast-moving consumer healthcare company in India.
SANOFICONR
₹4,652.10
7D
2.1%
1Y
-8.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹422.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,494.20
7D
-0.5%
1Y
-21.1%
Alivus Life Sciences
Market Cap: ₹135.4b
Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.
ALIVUS
₹1,102.80
7D
-5.3%
1Y
7.8%
Gland Pharma
Market Cap: ₹391.7b
Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.
GLAND
₹2,377.70
7D
-6.0%
1Y
17.8%
CORONA Remedies
Market Cap: ₹124.1b
A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.
CORONA
₹2,029.70
7D
-1.7%
1Y
n/a
AstraZeneca Pharma India
Market Cap: ₹196.8b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹7,873.60
7D
-2.7%
1Y
-12.7%
Blue Jet Healthcare
Market Cap: ₹109.1b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹576.50
7D
-2.0%
1Y
-29.0%
Anthem Biosciences
Market Cap: ₹438.1b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹777.85
7D
2.5%
1Y
2.6%
Emcure Pharmaceuticals
Market Cap: ₹354.4b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹1,869.50
7D
3.7%
1Y
31.2%
Neuland Laboratories
Market Cap: ₹236.4b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹18,427.70
7D
-1.8%
1Y
33.6%
Laurus Labs
Market Cap: ₹846.7b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,568.30
7D
0.7%
1Y
87.5%